d 3263  (Alomone Labs)


Bioz Verified Symbol Alomone Labs is a verified supplier
Bioz Manufacturer Symbol Alomone Labs manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Alomone Labs d 3263
    Cooperative effect of the Trpm8 agonist <t>D−3263</t> with Enzalutamide or Docetaxel in TRAMP PCa cell lines. ( A , B ) End−point PCR ( A ) and Western blotting ( B ) analyses showing the expression of Trpm8 in TRAMP C1 and C2 cell lines compared to normal mouse prostate AP, DLP and VP lobes. Gapdh was used as loading control. Experiments were performed in quadruplicate. ( C ) Western blotting analysis showing molecular signature of apoptotic cell death (Caspase−3 and Parp cleavage). TRAMP C1 and TRAMP C2 cells were treated with D−3263 (1 μM), Docetaxel (5 nM), Enzalutamide (1 μM), D-3263 + Docetaxel, or D-3263 + Enzalutamide for 24 or 72 h. Untreated cells were used as control. Gapdh was used as loading control. Experiments were performed in triplicates. * Protein extracts from cells treated with Staurosporine (1 μM, 6 h) were used as positive control.
    D 3263, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d 3263/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    d 3263 - by Bioz Stars, 2022-12
    94/100 stars

    Images

    1) Product Images from "Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies"

    Article Title: Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies

    Journal: Biomolecules

    doi: 10.3390/biom12020193

    Cooperative effect of the Trpm8 agonist D−3263 with Enzalutamide or Docetaxel in TRAMP PCa cell lines. ( A , B ) End−point PCR ( A ) and Western blotting ( B ) analyses showing the expression of Trpm8 in TRAMP C1 and C2 cell lines compared to normal mouse prostate AP, DLP and VP lobes. Gapdh was used as loading control. Experiments were performed in quadruplicate. ( C ) Western blotting analysis showing molecular signature of apoptotic cell death (Caspase−3 and Parp cleavage). TRAMP C1 and TRAMP C2 cells were treated with D−3263 (1 μM), Docetaxel (5 nM), Enzalutamide (1 μM), D-3263 + Docetaxel, or D-3263 + Enzalutamide for 24 or 72 h. Untreated cells were used as control. Gapdh was used as loading control. Experiments were performed in triplicates. * Protein extracts from cells treated with Staurosporine (1 μM, 6 h) were used as positive control.
    Figure Legend Snippet: Cooperative effect of the Trpm8 agonist D−3263 with Enzalutamide or Docetaxel in TRAMP PCa cell lines. ( A , B ) End−point PCR ( A ) and Western blotting ( B ) analyses showing the expression of Trpm8 in TRAMP C1 and C2 cell lines compared to normal mouse prostate AP, DLP and VP lobes. Gapdh was used as loading control. Experiments were performed in quadruplicate. ( C ) Western blotting analysis showing molecular signature of apoptotic cell death (Caspase−3 and Parp cleavage). TRAMP C1 and TRAMP C2 cells were treated with D−3263 (1 μM), Docetaxel (5 nM), Enzalutamide (1 μM), D-3263 + Docetaxel, or D-3263 + Enzalutamide for 24 or 72 h. Untreated cells were used as control. Gapdh was used as loading control. Experiments were performed in triplicates. * Protein extracts from cells treated with Staurosporine (1 μM, 6 h) were used as positive control.

    Techniques Used: Polymerase Chain Reaction, Western Blot, Expressing, Positive Control

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94
    Alomone Labs d 3263
    Cooperative effect of the Trpm8 agonist <t>D−3263</t> with Enzalutamide or Docetaxel in TRAMP PCa cell lines. ( A , B ) End−point PCR ( A ) and Western blotting ( B ) analyses showing the expression of Trpm8 in TRAMP C1 and C2 cell lines compared to normal mouse prostate AP, DLP and VP lobes. Gapdh was used as loading control. Experiments were performed in quadruplicate. ( C ) Western blotting analysis showing molecular signature of apoptotic cell death (Caspase−3 and Parp cleavage). TRAMP C1 and TRAMP C2 cells were treated with D−3263 (1 μM), Docetaxel (5 nM), Enzalutamide (1 μM), D-3263 + Docetaxel, or D-3263 + Enzalutamide for 24 or 72 h. Untreated cells were used as control. Gapdh was used as loading control. Experiments were performed in triplicates. * Protein extracts from cells treated with Staurosporine (1 μM, 6 h) were used as positive control.
    D 3263, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/d 3263/product/Alomone Labs
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    d 3263 - by Bioz Stars, 2022-12
    94/100 stars
      Buy from Supplier

    93
    Alomone Labs anti gaba transporter 1 gat 1 extracellular antibody
    The <t>GABA</t> reuptake function of the mutant <t>GAT-1(Val125Met)</t> transporter was reduced in non-neuronal cells and neurons. A-B. HEK293T cells or mouse cortical astrocytes were transfected with wildtype GAT-1 YFP (wt), or the mutant GAT-1(Val125Met, V125M) YFP cDNAs (1μg per a 35mm 2 dish) for 48 hrs before 3 H radioactive GABA uptake assay. C . Mouse cortical neurons were transfected with the wildtype or the mutant GAT-1(Val125Met) cDNAs at day 7 in culture. 3 H radioactive GABA uptake assay was performed after 8 days of transfection. GABA flux was measured after 30 min transport at room temperature. The influx of GABA, expressed in pmol/μg protein/min, was averaged from duplicates for each condition and for each transfection. The average counting was taken as n = 1. The untransfected condition was taken as baseline flux, which was subtracted from both the wildtype and the mutant conditions in HEK293T cells ( A ). The pmol/μg protein/min in the mutant was then normalized to the wildtype from each experiment, which was arbitrarily set as 100%. (***p
    Anti Gaba Transporter 1 Gat 1 Extracellular Antibody, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti gaba transporter 1 gat 1 extracellular antibody/product/Alomone Labs
    Average 93 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    anti gaba transporter 1 gat 1 extracellular antibody - by Bioz Stars, 2022-12
    93/100 stars
      Buy from Supplier

    Image Search Results


    Cooperative effect of the Trpm8 agonist D−3263 with Enzalutamide or Docetaxel in TRAMP PCa cell lines. ( A , B ) End−point PCR ( A ) and Western blotting ( B ) analyses showing the expression of Trpm8 in TRAMP C1 and C2 cell lines compared to normal mouse prostate AP, DLP and VP lobes. Gapdh was used as loading control. Experiments were performed in quadruplicate. ( C ) Western blotting analysis showing molecular signature of apoptotic cell death (Caspase−3 and Parp cleavage). TRAMP C1 and TRAMP C2 cells were treated with D−3263 (1 μM), Docetaxel (5 nM), Enzalutamide (1 μM), D-3263 + Docetaxel, or D-3263 + Enzalutamide for 24 or 72 h. Untreated cells were used as control. Gapdh was used as loading control. Experiments were performed in triplicates. * Protein extracts from cells treated with Staurosporine (1 μM, 6 h) were used as positive control.

    Journal: Biomolecules

    Article Title: Trpm8 Expression in Human and Mouse Castration Resistant Prostate Adenocarcinoma Paves the Way for the Preclinical Development of TRPM8-Based Targeted Therapies

    doi: 10.3390/biom12020193

    Figure Lengend Snippet: Cooperative effect of the Trpm8 agonist D−3263 with Enzalutamide or Docetaxel in TRAMP PCa cell lines. ( A , B ) End−point PCR ( A ) and Western blotting ( B ) analyses showing the expression of Trpm8 in TRAMP C1 and C2 cell lines compared to normal mouse prostate AP, DLP and VP lobes. Gapdh was used as loading control. Experiments were performed in quadruplicate. ( C ) Western blotting analysis showing molecular signature of apoptotic cell death (Caspase−3 and Parp cleavage). TRAMP C1 and TRAMP C2 cells were treated with D−3263 (1 μM), Docetaxel (5 nM), Enzalutamide (1 μM), D-3263 + Docetaxel, or D-3263 + Enzalutamide for 24 or 72 h. Untreated cells were used as control. Gapdh was used as loading control. Experiments were performed in triplicates. * Protein extracts from cells treated with Staurosporine (1 μM, 6 h) were used as positive control.

    Article Snippet: Fluo-4 fluorescence were recorded every 1 s for 60 s before and 540 s after bath application of D-3263 or vehicle.

    Techniques: Polymerase Chain Reaction, Western Blot, Expressing, Positive Control

    The GABA reuptake function of the mutant GAT-1(Val125Met) transporter was reduced in non-neuronal cells and neurons. A-B. HEK293T cells or mouse cortical astrocytes were transfected with wildtype GAT-1 YFP (wt), or the mutant GAT-1(Val125Met, V125M) YFP cDNAs (1μg per a 35mm 2 dish) for 48 hrs before 3 H radioactive GABA uptake assay. C . Mouse cortical neurons were transfected with the wildtype or the mutant GAT-1(Val125Met) cDNAs at day 7 in culture. 3 H radioactive GABA uptake assay was performed after 8 days of transfection. GABA flux was measured after 30 min transport at room temperature. The influx of GABA, expressed in pmol/μg protein/min, was averaged from duplicates for each condition and for each transfection. The average counting was taken as n = 1. The untransfected condition was taken as baseline flux, which was subtracted from both the wildtype and the mutant conditions in HEK293T cells ( A ). The pmol/μg protein/min in the mutant was then normalized to the wildtype from each experiment, which was arbitrarily set as 100%. (***p

    Journal: Experimental neurology

    Article Title: Genetic mosaicism, intrafamilial phenotypic heterogeneity, and molecular defects of a novel missense SLC6A1 mutation associated with epilepsy and ADHD

    doi: 10.1016/j.expneurol.2021.113723

    Figure Lengend Snippet: The GABA reuptake function of the mutant GAT-1(Val125Met) transporter was reduced in non-neuronal cells and neurons. A-B. HEK293T cells or mouse cortical astrocytes were transfected with wildtype GAT-1 YFP (wt), or the mutant GAT-1(Val125Met, V125M) YFP cDNAs (1μg per a 35mm 2 dish) for 48 hrs before 3 H radioactive GABA uptake assay. C . Mouse cortical neurons were transfected with the wildtype or the mutant GAT-1(Val125Met) cDNAs at day 7 in culture. 3 H radioactive GABA uptake assay was performed after 8 days of transfection. GABA flux was measured after 30 min transport at room temperature. The influx of GABA, expressed in pmol/μg protein/min, was averaged from duplicates for each condition and for each transfection. The average counting was taken as n = 1. The untransfected condition was taken as baseline flux, which was subtracted from both the wildtype and the mutant conditions in HEK293T cells ( A ). The pmol/μg protein/min in the mutant was then normalized to the wildtype from each experiment, which was arbitrarily set as 100%. (***p

    Article Snippet: Membranes were incubated with primary rabbit polyclonal antibodies against GAT-1 (Alomone Labs, AGT-001 or Synaptic System, 274102 at 1:200 dilution).

    Techniques: Mutagenesis, Transfection

    Electroencephalogram (EEG) of two sisters carrying the GAT-1(Val125Met) encoding mutation showing high amplitude burst of 3 Hz spike wave discharges and prominent occipital intermittent rhythmic delta activity (OIRDA). (A, B) Prominent bursts of Occipital Intermittent Rhythmic Delta Activity in the Proband (A, age 8) and Patient 2 (B, age 4) occurred throughout the waking state. (C, D) recordings showed sudden burst of generalized high amplitude bursts of 3.0 Hz spike and slow waves in proband ( C ) and the half-sister ( D ). ( E, F ), Typical absence for proband was associated with a myoclonic jerk and loss of tone—noted by muscle artifact (red arrows), sensitivity 15 microvolts (E) and a typical abnormal spike wave discharges for patient 2 ( D ) arising out of sleep, which was asymptomatic. Sensitivity 15 microvolts.

    Journal: Experimental neurology

    Article Title: Genetic mosaicism, intrafamilial phenotypic heterogeneity, and molecular defects of a novel missense SLC6A1 mutation associated with epilepsy and ADHD

    doi: 10.1016/j.expneurol.2021.113723

    Figure Lengend Snippet: Electroencephalogram (EEG) of two sisters carrying the GAT-1(Val125Met) encoding mutation showing high amplitude burst of 3 Hz spike wave discharges and prominent occipital intermittent rhythmic delta activity (OIRDA). (A, B) Prominent bursts of Occipital Intermittent Rhythmic Delta Activity in the Proband (A, age 8) and Patient 2 (B, age 4) occurred throughout the waking state. (C, D) recordings showed sudden burst of generalized high amplitude bursts of 3.0 Hz spike and slow waves in proband ( C ) and the half-sister ( D ). ( E, F ), Typical absence for proband was associated with a myoclonic jerk and loss of tone—noted by muscle artifact (red arrows), sensitivity 15 microvolts (E) and a typical abnormal spike wave discharges for patient 2 ( D ) arising out of sleep, which was asymptomatic. Sensitivity 15 microvolts.

    Article Snippet: Membranes were incubated with primary rabbit polyclonal antibodies against GAT-1 (Alomone Labs, AGT-001 or Synaptic System, 274102 at 1:200 dilution).

    Techniques: Mutagenesis, Activity Assay

    Both the total and cell surface expression of the mutant GAT-1(Val125Met) transporter protein was reduced. A, B . HEK293T cells were transfected with wildtype GAT-1 YFP (wt), or the mutant GAT-1(Val125Met, V125M) YFP cDNAs (3μg/60 mm 2 ) for 48 hrs. The cells ( A ) were either harvested directly after wash with PBS for total lysates or followed by cell surface biotinylation to isolate the cell surface bound proteins ( B ). The total lysates ( A) or isolated surface protein ( B) were then analyzed by SDS-PAGE. Membranes were immunoblotted with rabbit anti-GAT-1 (1:300). ( C ). The total protein integrated density values (IDVs) from the total lysates ( C ) or isolated cell surface protein ( D ) were measured. The abundance of the mutant GAT-1(Val125Met) transporter was normalized to the wildtype cells expressing GAT-1 YFP . In C , the total protein abundance was measured by adding up all the bands between 90-110 KDa. The total protein IDVs of either the wildtype or the mutant was normalized to its loading control. The abundance of the mutant transporter was then normalized to the wildtype. (**p

    Journal: Experimental neurology

    Article Title: Genetic mosaicism, intrafamilial phenotypic heterogeneity, and molecular defects of a novel missense SLC6A1 mutation associated with epilepsy and ADHD

    doi: 10.1016/j.expneurol.2021.113723

    Figure Lengend Snippet: Both the total and cell surface expression of the mutant GAT-1(Val125Met) transporter protein was reduced. A, B . HEK293T cells were transfected with wildtype GAT-1 YFP (wt), or the mutant GAT-1(Val125Met, V125M) YFP cDNAs (3μg/60 mm 2 ) for 48 hrs. The cells ( A ) were either harvested directly after wash with PBS for total lysates or followed by cell surface biotinylation to isolate the cell surface bound proteins ( B ). The total lysates ( A) or isolated surface protein ( B) were then analyzed by SDS-PAGE. Membranes were immunoblotted with rabbit anti-GAT-1 (1:300). ( C ). The total protein integrated density values (IDVs) from the total lysates ( C ) or isolated cell surface protein ( D ) were measured. The abundance of the mutant GAT-1(Val125Met) transporter was normalized to the wildtype cells expressing GAT-1 YFP . In C , the total protein abundance was measured by adding up all the bands between 90-110 KDa. The total protein IDVs of either the wildtype or the mutant was normalized to its loading control. The abundance of the mutant transporter was then normalized to the wildtype. (**p

    Article Snippet: Membranes were incubated with primary rabbit polyclonal antibodies against GAT-1 (Alomone Labs, AGT-001 or Synaptic System, 274102 at 1:200 dilution).

    Techniques: Expressing, Mutagenesis, Transfection, Isolation, SDS Page

    Modeling of the mutant GAT-1(Val125Met) protein with machine learning tools. ( A-B ). Tertiary structures of both the wildtype ( A ) and Val125Met mutant ( B ) GAT-1 protein are predicted by I-TASSER and DynaMut. The valine at residue 125 is mutated to methionine, both highlighted in light green, alongside with the surrounding residues. The interatomic interactions were predicted by DynaMut, where halogen bonds are depicted in blue and hydrogen bonds are colored in red. The Val125Met mutation results in the addition of sulfur into the sidechain, not causing drastic changes in polarity and charge, but making the protein less hydrophobic. ( C ). Machine learning tools predicted ΔΔG (Kcal/mol) of the mutant GAT-1(Val125Met) protein. Bars in the positive direction are predicted as stabilizing while bars in the negative direction are predicted as destabilizing.

    Journal: Experimental neurology

    Article Title: Genetic mosaicism, intrafamilial phenotypic heterogeneity, and molecular defects of a novel missense SLC6A1 mutation associated with epilepsy and ADHD

    doi: 10.1016/j.expneurol.2021.113723

    Figure Lengend Snippet: Modeling of the mutant GAT-1(Val125Met) protein with machine learning tools. ( A-B ). Tertiary structures of both the wildtype ( A ) and Val125Met mutant ( B ) GAT-1 protein are predicted by I-TASSER and DynaMut. The valine at residue 125 is mutated to methionine, both highlighted in light green, alongside with the surrounding residues. The interatomic interactions were predicted by DynaMut, where halogen bonds are depicted in blue and hydrogen bonds are colored in red. The Val125Met mutation results in the addition of sulfur into the sidechain, not causing drastic changes in polarity and charge, but making the protein less hydrophobic. ( C ). Machine learning tools predicted ΔΔG (Kcal/mol) of the mutant GAT-1(Val125Met) protein. Bars in the positive direction are predicted as stabilizing while bars in the negative direction are predicted as destabilizing.

    Article Snippet: Membranes were incubated with primary rabbit polyclonal antibodies against GAT-1 (Alomone Labs, AGT-001 or Synaptic System, 274102 at 1:200 dilution).

    Techniques: Mutagenesis